Paperpal Prime Logo

Current Pharmaceutical Design : Impact Factor & More

eISSN: 1873-4286pISSN: 1381-6128

Aims and Scope of Current Pharmaceutical Design

Current Pharmaceutical Design is a peer-reviewed medical journal which covers issues related to pharmacology and medicinal chemistry. Each issue is devoted to a single major therapeutic area. For each issue, an executive editor is chosen who is an acknowledged authority in that field. Less

Key Metrics

CiteScore
5.8
H-Index
176
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.73
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Pharmaceutical Design

Current Pharmaceutical Design Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher BENTHAM SCIENCE PUBL LTD
Language English
Frequency Weekly
General Details
LanguageEnglish
FrequencyWeekly
Publication Start Year1995
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Current Pharmaceutical Design ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Current Pharmaceutical Design

Formulation, Characterization, and Preliminary In Vitro Evaluation of Letrozole Incorporated Eudragit® RS 100 Nanoparticles Using HepG2 Cells.
  • 25 Jul 2026
  • Current pharmaceutical design
Modern Trends in the Development of Natural and Synthetic Anti-Tuberculosis Drugs.
  • 25 Jul 2026
  • Current pharmaceutical design
Nutritional Adjuvants in Diabetes: Biotin and Chromium Picolinate as Emerging Therapeutic Agents.
  • 25 Jul 2026
  • Current pharmaceutical design
Integrated Network Pharmacology and Experimental Study: Bioactive Compounds and Mechanisms of XuanTong BuLuo Decoction in Treating Diabetic Cardiomyopathy.
  • 24 Jul 2026
  • Current pharmaceutical design
Harnessing Natural Bioactive Compounds for Ocular Health: A Comprehensive Review.
  • 23 Jul 2026
  • Current pharmaceutical design
A Comprehensive Review of Phosphodiesterases 4 (PDE4) Inhibitors in Clinical Trials.
  • 23 Jul 2026
  • Current pharmaceutical design
Formulation, Characterization, and Preliminary In Vitro Evaluation of Letrozole Incorporated Eudragit® RS 100 Nanoparticles Using HepG2 Cells.
  • 25 Jul 2026
  • Current pharmaceutical design
Modern Trends in the Development of Natural and Synthetic Anti-Tuberculosis Drugs.
  • 25 Jul 2026
  • Current pharmaceutical design
Nutritional Adjuvants in Diabetes: Biotin and Chromium Picolinate as Emerging Therapeutic Agents.
  • 25 Jul 2026
  • Current pharmaceutical design
Integrated Network Pharmacology and Experimental Study: Bioactive Compounds and Mechanisms of XuanTong BuLuo Decoction in Treating Diabetic Cardiomyopathy.
  • 24 Jul 2026
  • Current pharmaceutical design
Harnessing Natural Bioactive Compounds for Ocular Health: A Comprehensive Review.
  • 23 Jul 2026
  • Current pharmaceutical design
A Comprehensive Review of Phosphodiesterases 4 (PDE4) Inhibitors in Clinical Trials.
  • 23 Jul 2026
  • Current pharmaceutical design

FAQs on Current Pharmaceutical Design